Rare diseases
Investigational molecules
Locations
Back to France929 clinical trials in Villejuif, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer
FranceStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
FranceStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
FranceStudy of Gemcitabine with Paclitaxel versus Standard Chemotherapy Combination for Patients with Borderline Resectable Pancreatic Cancer Based on Gene Analysis
FranceStudy of FOLFOX or FOLFIRI chemotherapy with fruquintinib or bevacizumab as second-line treatment for patients with metastatic colorectal cancer
FranceStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
FranceStudy of Human Albumin Treatment to Prevent Kidney Dysfunction in Adult Patients After Liver Transplantation
FranceStudy of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab
FranceStudy of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors
FranceEvaluating Elacestrant alone or with leuprorelin in premenopausal women with early-stage hormone receptor positive breast cancer before surgery
FranceStudy of MP0317 with durvalumab, gemcitabine and cisplatin combination therapy as first-line treatment for patients with advanced biliary tract cancer
FranceStudy of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on locally advanced head and neck squamous cell carcinoma treatments, including novel therapies combined with radiotherapy and immunotherapy approaches.
Studies targeting various digestive system cancers, with particular focus on pancreatic adenocarcinoma and advanced gastric cancer treatments.
Cutting-edge research in multiple myeloma treatment, exploring new combination therapies and maintenance approaches.
Comprehensive studies in both non-small cell lung cancer and small cell lung cancer, investigating targeted therapies and immunotherapy combinations.
Broad-spectrum research investigating novel treatments for metastatic solid tumors, including innovative therapeutic approaches and combination strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
